Loading clinical trials...
Loading clinical trials...
Multi-center, Single Arm Continued Access Protocol to Evaluate the Mid-Bore Venous VCS for the Management of the Femoral Venotomy After Catheter-based Interventions Via 6-12F Procedural Sheaths With Single or Multiple Access Sites Per Limb
Conditions
Interventions
Cardiva Mid-Bore Venous Vascular Closure Device (VVCS)
Locations
3
United States
Emory St. Joseph's Hospital
Atlanta, Georgia, United States
Valley Hospital
Ridgewood, New Jersey, United States
Texas Cardiac Arrhythmia Research Foundation
Austin, Texas, United States
Start Date
August 27, 2018
Primary Completion Date
January 14, 2019
Completion Date
March 31, 2019
Last Updated
March 10, 2023
NCT07379684
NCT03561376
NCT06578650
NCT05389410
NCT06319235
NCT06558240
Lead Sponsor
Cardiva Medical, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions